USP8 and glioblastoma: In summary, by demonstrating the effectiveness of pharmacological USP8 inhibition in suppressing GBM cell growth, migration, and stemness, as well as in promoting the sensitivity of GBM cells to radiotherapy, our findings suggest USP8 as a potential therapeutic target for the treatment of GBM, warranting further investigation.